Regeneron Pharmaceuticals (REGN)
(Delayed Data from NSDQ)
$976.96 USD
+3.16 (0.32%)
Updated May 13, 2024 04:00 PM ET
After-Market: $977.99 +1.03 (0.11%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/01/2024
Time: -- |
6/2024 | $10.67 | 1.46% |
Earnings Summary
For their last quarter, Regeneron Pharmaceuticals (REGN) reported earnings of $9.55 per share, missing the Zacks Consensus Estimate of $10.20 per share. This reflects a negative earnings surprise of 6.37%. Look out for REGN's next earnings release expected on August 01, 2024. For the next earning release, we expect the company to report earnings of $10.67 per share, reflecting a year-over-year increase of 4.2%.
Earnings History
Price & Consensus
Zacks News for REGN
Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)?
REGN: What are Zacks experts saying now?
Zacks Private Portfolio Services